All news (page 38)

• 

  14 April 2026

  Dow appoints Karen S. Carter CEO; Jim Fitterling becomes Executive Chair

  Effective July 1, 2026, Jim Fitterling shifts from CEO to Executive Chair; COO Karen S. Carter succeeds him as CEO and joins the board after a multi-year succession plan.
• 

  14 April 2026

  thyssenkrupp-backed European Resilience Alliance launches to scale clean hydrogen deployment

  CEO-led alliance white paper diagnoses bottlenecks—fragmented rules, high power costs, weak demand certainty—and urges bankable demand, simpler support, de-risk finance and cross-border infrastructure
• 

  14 April 2026

  Genmab: DARZALEX Q1 2026 net sales USD 3,964m

  DARZALEX Q1 sales split: US $2,208m; RoW $1,756m. Includes subcutaneous FASPRO in U.S. Royalties received under J&J exclusive license.
• 

  14 April 2026

  Brenntag appointed BASF Keropur distributor for Europe and Turkey

  Will expand supply of fuel-additive packages to fuel retailers, terminals and wholesalers, improving deposit control, conductivity, cetane, anti-foam, anti-corrosion, drivability and emissions.
• 

  14 April 2026

  Evonik and Uniper commission high‑temperature heat pump in Herne

  High-temperature heat pump uses 25–30°C industrial waste heat to supply ~1,000 households (up to 1.5 MW) via district heating, cutting ~1,750 t CO₂/yr; pilot with scaling potential.
• 

  14 April 2026

  WACKER and Amyris partner on bio-based personal-care ingredients

  Develop bio-based functional ingredients for cosmetics; expand silicone range with renewable raw materials; test novel molecules and production integration.

• 

  14 April 2026

  Novo Nordisk partners with OpenAI to speed drug discovery and delivery

  Integrate advanced AI across drug discovery, manufacturing, supply chain and commercial ops to speed development, upskill staff; pilots now, full integration by end-2026; strict governance.
• 

  14 April 2026

  OCI Global sells 2M Methanex shares for ~$116.6M

  Block trade on 13 April; ownership fell from ~6.0% to ~3.4%. Transaction was for investment purposes; company may repurchase or further sell shares depending on market and the stock's performance.
• 

  14 April 2026

  AGC Pharma Chemicals named Best-in-Class in four CDMO Leadership Awards 2026 categories

  Selected via client evaluations and Tufts CSDD, praised for specialized staff, cultural fit, tech use and scaling support; offers cGMP CDMO services across Japan, US, EU and supports varied modalities
• 

  13 April 2026

  RAB Lighting adopts Röhm’s PLEXIGLAS® proTerra 8N for C‑Wall covers

  Bio‑circular PMMA lowers cradle‑to‑gate CO2e by 25%, fits existing processes, offers 92% light transmission, UV/weather resistance and light‑guiding properties.
• 

  13 April 2026

  ARLANXEO exclusively markets PRC-produced EPDM under Keltan KSA

  Agreement expanded Feb 2026 to include EPDM grades. EPDM used in seals, hoses and gaskets; resists water, ozone, UV and heat; flexible, durable, wide temperature range and good electrical properties.
• 

  13 April 2026

  Toray Composite Materials America and Syensqo sign five-year carbon-fiber supply agreement for aerospace

  Five-year carbon-fiber supply deal (effective Jan 2026) to secure supply for aircraft, space and defense, strengthening the global chain amid rising aerospace demand
• 

  13 April 2026

  Petrobras greenlights SEAP I FID and advances contracting of two Sergipe‑Alagoas platforms

  SEAP II FID had been approved earlier. SBM Offshore to build two BOT FPSOs with combined 240,000 bbl/d and 22 MMm3/d gas. Contract signing May 2026; production ~2030/2031; investment >R$60bn.
• 

  13 April 2026

  Petrobras approves restart of UFN III fertilizer plant construction in Três Lagoas

  Board approved resumption of UFN III construction; ~$1B to complete, operations in 2029; ~8,000 construction jobs; capacity ~3,600 t/d urea and 2,200 t/d ammonia; strategic for domestic supply
• 

  13 April 2026

  Nouryon expands China production of Levasil colloidal silica for catalysts and coatings

  Guangzhou capacity boost shortens lead times for APAC manufacturers, supporting emissions catalysts, electrical-steel and cookware coatings; follows Shanghai innovation center with Levasil lab
• 

  13 April 2026

  Clariant launches Hostapon CT solid, a salt-free mild taurate surfactant

  New surfactant offers 90% actives, long-lasting silky foam, strong oil stability, low-salt formulation flexibility, mildness for dry/sensitive skin, 80% RCI and ready biodegradability.
• 

  13 April 2026

  Lucas Meyer Cosmetics by Clariant unveils AlgaSurge, Lysofix Liquid and LightYears at in-cosmetics 2026

  Introduces a microalgae skin longevity active that boosts hydration, collagen and renewal, and reduces inflammation and spots. Emulsifier data: soothes, repairs barrier and improves hair combing.
• 

  13 April 2026

  Honeywell to supply liquefaction technology for Rio Grande LNG Trains 4–5

  NextDecade will use CWHE and C3MR via Bechtel to boost reliability, cut OPEX and increase LNG output from 18 to 30 MTPA; all five trains expected online by mid-2031.
• 

  13 April 2026

  Genmab: Rina‑S plus bevacizumab tolerable in advanced ovarian cancer

  RAINFOL‑01 D2 (n=40): common TEAEs—nausea 80%, fatigue 67.5%, anemia 55%, neutropenia 45%; serious TEAEs 15%; dose reductions 27.5%; no fatal TEAEs. Phase 3 RAINFOL‑04 ongoing.
• 

  13 April 2026

  Daiichi Sankyo and Merck: FDA Priority Review for Ifinatamab Deruxtecan in ES‑SCLC

  BLA for ifinatamab deruxtecan accepted and granted FDA Priority Review for adult ES‑SCLC post‑platinum therapy; PDUFA Oct 10, 2026. Based on IDeate‑Lung01 Phase 2 (B7‑H3 DXd ADC).
• 

  13 April 2026

  Johnson & Johnson reports positive 12‑month VARIPULSE results at EHRA 2026

  12‑month post‑market study: 84.2% freedom from atrial arrhythmia (90.5% paroxysmal; 75.3% persistent); 0.8% primary adverse events; CE‑mark allows ablation beyond pulmonary veins
• 

  13 April 2026

  Lilly: Jaypirca plus venetoclax‑rituximab extends PFS in previously treated CLL/SLL

  Phase 3 BRUIN CLL-322 (n=639) in relapsed/refractory CLL/SLL: time-limited (2-yr) pirtobrutinib with venetoclax+rituximab showed consistent benefit across subgroups; safety similar; OS immature.
• 

  13 April 2026

  Petrobras discovers hydrocarbons in deepwater pre‑salt Campos Basin well

  Hydrocarbons found in pre-salt of Campos Basin (block C‑M‑477) in exploratory well 201 km off Rio de Janeiro at 2,984 m water depth; presence confirmed by logs, gas shows and fluid samples.
• 

  13 April 2026

  bp to acquire 60% interest in three Namibian offshore exploration blocks

  Subject to Namibian approvals, the acquirer will operate PEL97, PEL99 and PEL100 in the Walvis Basin; Eco Atlantic and NAMCOR remain partners. Move builds on recent Azule Energy discoveries.
• 

  13 April 2026

  Boehringer Ingelheim launches LENZELTA mastitis vaccine

  LENZELTA reduces incidence and severity of clinical mastitis in cows and heifers. Two dry‑off doses deliver early immunity and up to six months' protection vs S. aureus and E. coli.
• 

  13 April 2026

  QatarEnergy finds hydrocarbons offshore Republic of Congo

  Discovery in MHNM-6 NFW well on Moho G offshore Congo: 160m hydrocarbon column in good-quality Albian reservoirs; data and samples collected for subsurface interpretation.
• 

  13 April 2026

  Roche's Elecsys NfL CE‑marked to monitor neuroinflammation in RRMS

  New blood test detects neuroaxonal damage, enabling minimally invasive, more accessible monitoring of neuroinflammation, complementing MRI and supporting earlier clinical intervention
• 

  12 April 2026

  GSK Mo‑Rez (B7‑H4 ADC) achieves 62% ORR in platinum‑resistant ovarian and 67% in endometrial cancer

  BEHOLD-1 phase I: Mo-Rez (B7-H4 ADC) active across expression levels; manageable hematologic toxicity and nausea. 5.8 mg/kg recommended; five Phase III trials planned 2026
• 

  10 April 2026

  Perstorp appoints NiMAC as UK distributor for Synthetic-EF

  UK lubricant makers gain local access to saturated synthetic polyol ester base fluids and formulators get technical support via a new distribution tie-up.
• 

  10 April 2026

  Plenitude acquires Acea Energia

  100% of an energy retail arm and 50% of a regional supplier acquired; adds 1.2M customers. Vulnerable customers excluded. Price ~€500M plus up to €100M earn‑out to 30/06/2027.